Amprion

Private

San Diego, CaliforniaHealthcare & Life Scienceshttps://www.ampriondx.com/

Last Round

Series B

Oct 9, 2024

Total Funding Raised

$16.66M

Company Overview

Amprion is a biotechnology company that develops diagnostic tests to detect misfolded proteins for the early diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Data as a Service

AI Layer

Non-AI

Keywords

seed amplification assaySAAalpha-synuclein detectionneurodegenerative diagnosticsmisfolded protein detectionParkinson's disease diagnosisLewy body dementialaboratory-developed testLDTsynucleinopathiesbiopharma servicesclinical trial supportpatient stratificationcompanion diagnosticsbiomarker validationFDA Breakthrough DeviceCLIA-certified lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amprion Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Amprion Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Oct 9, 2024
Grant	Sep 12, 2024
Grant	May 10, 2022
Grant	Apr 15, 2021
Grant	Nov 15, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Russ Lebovitz

CEO

Executive Team

Richard Narido

Chief Financial Officer

Executive Team

Amprion Investors

Notable investors and investment history

Investor	Rounds
Formation Venture Engineering	Series B
ALS Network	Grant
National Institute of Neurological Disorders and Stroke	Grant
Alzheimer's Drug Discovery Foundation	Grant, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 14, 2025
Monthly visitors increased 59% MoM.
Jun 2, 2025
Monthly visitors grew 42% MoM, reaching 1.7K.

View all signals

Amprion Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Amprion Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amprion's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California

Employee Range38

Year Founded2007

Last FundingOct 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.